|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 183.82 DKK | +4.68% |
|
+7.90% | -3.35% |
| 02:09pm | Bavarian Nordic Bags DKK200 Million Order for Smallpox/Mpox Vaccine | MT |
| 10/07 | Bavarian Nordic Secures Vaccine Order Worth Over 200 Million Danish Kroner from Unnamed European Country | FW |
| Capitalization | 13.67B 2.14B 1.83B 1.71B 1.58B 2.94B 184B 3.29B 20.43B 7.77B 85.89B 8.04B 7.88B 314B | P/E ratio 2025 * |
10x | P/E ratio 2026 * | 19.3x |
|---|---|---|---|---|---|
| Enterprise value | 10.56B 1.66B 1.42B 1.32B 1.22B 2.27B 142B 2.54B 15.79B 6.01B 66.38B 6.22B 6.09B 243B | EV / Sales 2025 * |
1.67x | EV / Sales 2026 * | 1.74x |
| Free-Float |
98.02% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Bavarian Nordic A/S
More recommendations
More press releases
More news
| 1 day | +4.61% | ||
| 1 week | +7.90% | ||
| Current month | +8.32% | ||
| 1 month | -2.66% | ||
| 3 months | +25.77% | ||
| 6 months | -9.23% | ||
| Current year | -3.35% |
| 1 week | 166.7 |  | 185.45 |
| 1 month | 165.8 | | 188.05 |
| Current year | 123.3 | | 210 |
| 1 year | 123.3 | | 300 |
| 3 years | 123.3 | | 411 |
| 5 years | 115.2 | | 411 |
| 10 years | 103.2 | | 444 |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Chaplin
CEO | Chief Executive Officer | 58 | 28/05/2014 |
Henrik Juuel
DFI | Director of Finance/CFO | 60 | 01/11/2018 |
Russell Thirsk
COO | Chief Operating Officer | 57 | 01/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 74 | 27/04/2010 | |
Frank Verwiel
BRD | Director/Board Member | 62 | 20/04/2016 |
Anne Eberhard
BRD | Director/Board Member | 62 | 24/04/2019 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.68% | +7.90% | -2.19% | -23.69% | 2.14B | ||
| +0.70% | +1.38% | -15.79% | +139.05% | 706B | ||
| +1.38% | +1.42% | +5.89% | -11.28% | 376B | ||
| +2.37% | +2.77% | +15.69% | +26.94% | 337B | ||
| +2.40% | +2.84% | -53.87% | +11.06% | 309B | ||
| +0.94% | +1.55% | +5.06% | -19.87% | 262B | ||
| +1.82% | +2.42% | +0.85% | +19.45% | 240B | ||
| +2.62% | +3.84% | -12.27% | -5.00% | 218B | ||
| +0.93% | +4.85% | -33.34% | -10.01% | 210B | ||
| +1.25% | +0.53% | -6.79% | +21.01% | 159B | ||
| Average | +1.95% | +0.85% | -9.68% | +14.77% | 281.98B | |
| Weighted average by Cap. | +1.54% | +0.44% | -10.47% | +37.61% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 6.34B 994M 849M 791M 732M 1.36B 85.22B 1.52B 9.47B 3.6B 39.81B 3.73B 3.65B 146B | 5.39B 846M 723M 674M 623M 1.16B 72.53B 1.3B 8.06B 3.07B 33.89B 3.17B 3.11B 124B |
| Net income | 1.41B 221M 189M 176M 163M 303M 18.95B 339M 2.11B 801M 8.85B 829M 812M 32.4B | 716M 112M 95.94M 89.41M 82.69M 154M 9.63B 172M 1.07B 407M 4.5B 421M 413M 16.46B |
| Net Debt | -3.1B -487M -416M -388M -359M -667M -41.75B -746M -4.64B -1.77B -19.51B -1.83B -1.79B -71.38B | -4.27B -670M -572M -533M -493M -918M -57.42B -1.03B -6.38B -2.43B -26.83B -2.51B -2.46B -98.15B |
More financial data
* Estimated data
Employees
1,645
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/07/25 | 182.90 kr | +4.16% | 280,054 |
| 09/07/25 | 175.60 kr | +1.97% | 233,986 |
| 08/07/25 | 172.20 kr | +1.53% | 121,863 |
| 07/07/25 | 169.60 kr | -2.05% | 117,135 |
| 04/07/25 | 173.15 kr | +2.09% | 139,735 |
Delayed Quote Nasdaq Copenhagen, 11 July 2025 at 12:31 am AEST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
175.60DKK
Average target price
259.67DKK
Spread / Average Target
+47.87%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BAVA Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition